Podcasts

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Alyssa Perry, PharmD to discuss the pharmacist’s role in ensuring inclusive and respectful care for members of the LGBTQ+ community.

As clinical roles expand, the need for robust pharmacy infrastructure to streamline workflows and ensure medication access has never been more critical.

This episode explores the true price of commitment to a dream or vision, explaining how anything less than full dedication can lead to failure and why small wins are essential for perseverance.

In an evolving health care landscape bringing all providers into a primary care team, diabetes is no different and the pharmacist community can offer so much for patients.

Episode 10 addresses recent changes to the AACE diabetes guidelines and what pharmacists need to do to stay informed.

Featuring pharmacist and entrepreneur Sam Maddula, PharmD, this episode explores some key legislative and regulatory insights regarding owning and operating a pharmacy business.

In a health care landscape of silos and fragmentation, especially in the menopause space, pharmacists have increasingly provided their efforts to better care coordination for their communities.

In this episode, host Taylor Watterson, PharmD, PhD, provides a deeper look into workplace fatigue and the metrics used to calculate and facilitate it.

From PBM reform and AI to burnout and closures, Tom DePietro, PharmD, addresses the current state of independent pharmacy.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Sarah Chew, MPH, to discuss the pharmacist’s role in advancing women’s health research.

As diabetes rises to be one of the most prominent chronic diseases globally, pharmacists have reached out as key resources for preventing and managing its complications.

This episode explores the differences between behavior that is caught rather than taught, explaining how leadership can be a learned skill if properly approached.

With value-based care initiatives on the rise in the US health care system, one partnership in Ohio is showing early signs of significant success.

Episode 10 explores recent guideline changes in clinicians’ management of dyslipidemia, highlighting much more than a few updated recommendations.

Amid shifting vaccine recommendations and an evolving health care landscape, pharmacists continue to weather the storm as frontline community immunizers.

In this episode, host Taylor Watterson, PharmD, PhD, brings us a solo rendition breaking down some of her recent research with SCRPTS Laboratory.

In an evolving pharmacy landscape, accreditation can be difficult to manage, which is why experts like Mitch Lamb, PharmD, can steer businesses onto their desired paths.

This episode highlights key DSCSA updates in 2026, T3 documentation going forward, and many more developments surrounding the law.

With a 7-year target date, the FDA is moving away from 10-digit NDCs and toward a universal 12-digit format.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Kami Dixon, MD, MA, to discuss the racial disparities across women’s health in the US.

This episode explores the gaps between pharmacy leaders and the communities, and patients, that they serve.

With workforce and work-life balance issues plaguing pharmacy, the newly introduced hybrid pharmacist role is creating innovation across the greater pharmacy industry.

Episode 9 dives into the landscape of obesity pharmacotherapy, detailing current therapies, clinical updates, future pipelines, and more.

With a slew of new GLP-1 indications approved in recent history, researchers and experts are now diving into their use in treating substance use disorders.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Emily Hoffins, MS, PhD, postdoctoral researcher in the SCRPTS Lab at the University of Illinois Chicago Retzky College of Pharmacy.

Amid recent comments from FDA Commissioner Marty Makary, MD, MPH, that “everything should be OTC,” Mark Garofoli, PharmD, BCGP, CPE, CTTS, helps pharmacists understand what lies ahead.

In a bonus episode of the Over the Counter podcast, William A. Bryson, PharmD, joined to help celebrate Diabetes Alert Day—recognized annually on the fourth Tuesday in March.

This episode highlights the landmark FTC settlement with Express Scripts and what independent pharmacies and plan sponsors can expect going forward.

With ongoing concerns about the safety and formulation of compounded GLP-1s, Annie Lambert, PharmD, BCSCP, added her expert insights into the recent crackdown of these products.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Paul Weidle, PharmD, MPH, to discuss HIV care among women and girls.